Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.
Graham Witcomb, CFA of The Intelligent Investor joins Owen Rask on The Australian Investors Podcast to talk markets, psychology, life & more.
The S&P/ASX 200 (INDEXASX: XJO) started Tuesday with a mixed day. The ASX 200 price was up 0.3% with the EML Payments Ltd (ASX:EML) share price and Link (ASX:LNK) share price in focus.
The Ramsay Health Care Limited (ASX:RHC) share price could be one of the risers today after receiving a takeover offer.
The Fisher & Paykel Healthcare Corp Ltd (ASX:FPH) share price has sunk more than 5% after giving investors a trading update.
Cathie Wood’s ARK Genomic Revolution ETF (BATS: ARKG) and ASX-listed biotech stocks have been beaten up mercilessly, so is now the time to buy?
In this final part of our mini-series on ethical investing, Mike Murray from Australian Ethical outlines his thesis for three ASX companies that are owned by the Australian Ethical High Conviction ETF.
The Virtus Health Ltd (ASX:VRT) share price is in focus as elective surgeries are suspended due to the current Omicron COVID-19 wave.
The Cochlear Limited (ASX:COH) share price is up after providing an update about news from the US Food and Drug Administration (FDA).
The Ramsay Health Care Limited (ASX:RHC) share price is in the spotlight after the private hospital stock warned of potential COVID impacts.
Graham Witcomb, CFA of The Intelligent Investor joins Owen Rask on The Australian Investors Podcast to talk markets, psychology, life & more.
The S&P/ASX 200 (INDEXASX: XJO) started Tuesday with a mixed day. The ASX 200 price was up 0.3% with the EML Payments Ltd (ASX:EML) share price and Link (ASX:LNK) share price in focus.
The Ramsay Health Care Limited (ASX:RHC) share price could be one of the risers today after receiving a takeover offer.
The Fisher & Paykel Healthcare Corp Ltd (ASX:FPH) share price has sunk more than 5% after giving investors a trading update.
Cathie Wood’s ARK Genomic Revolution ETF (BATS: ARKG) and ASX-listed biotech stocks have been beaten up mercilessly, so is now the time to buy?
In this final part of our mini-series on ethical investing, Mike Murray from Australian Ethical outlines his thesis for three ASX companies that are owned by the Australian Ethical High Conviction ETF.
The Virtus Health Ltd (ASX:VRT) share price is in focus as elective surgeries are suspended due to the current Omicron COVID-19 wave.
The Cochlear Limited (ASX:COH) share price is up after providing an update about news from the US Food and Drug Administration (FDA).
The Ramsay Health Care Limited (ASX:RHC) share price is in the spotlight after the private hospital stock warned of potential COVID impacts.
Want to level-up your analytical skills and investing insights but don’t know where to start? We can help. Join 40,000+ Australian investors on our mailing list today and we’ll send you our favourite podcasts, courses, resources, investment articles and podcasts every week. Delivered to your inbox every Sunday morning. Grab a coffee and let Owen and the team bring you the best investment insights every week.
